BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15812458)

  • 1. Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening.
    Dubey P; Raymond GV; Moser AB; Kharkar S; Bezman L; Moser HW
    J Pediatr; 2005 Apr; 146(4):528-32. PubMed ID: 15812458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Detection of Adrenal Insufficiency: The Impact of Newborn Screening for Adrenoleukodystrophy.
    Ramirez Alcantara J; Grant NR; Sethuram S; Nagy A; Becker C; Sahai I; Stanley T; Halper A; Eichler FS
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1306-e1315. PubMed ID: 37220095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Changing Face of Adrenoleukodystrophy.
    Zhu J; Eichler F; Biffi A; Duncan CN; Williams DA; Majzoub JA
    Endocr Rev; 2020 Aug; 41(4):577-93. PubMed ID: 32364223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impacts of adrenoleukodystrophy newborn screening on the evaluation of adrenal dysfunction in male children: An integrative literature review.
    Pitts L; White JM; Ladores S; Wilson CM
    J Pediatr Nurs; 2023; 72():e53-e70. PubMed ID: 37331834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent episodes of vomiting and diarrhoea in a male child: a rare presentation of X-linked adrenoleukodystrophy.
    Gupta P; Keller SR; Patterson B
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35948360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive and mental health impact of adrenoleukodystrophy across the lifespan: Insights for the era of newborn screening.
    Pierpont EI; Isaia AR; McCoy E; Brown SJ; Gupta AO; Eisengart JB
    J Inherit Metab Dis; 2023 Mar; 46(2):174-193. PubMed ID: 36527290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients.
    Laureti S; Casucci G; Santeusanio F; Angeletti G; Aubourg P; Brunetti P
    J Clin Endocrinol Metab; 1996 Feb; 81(2):470-4. PubMed ID: 8636252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Onset Primary Adrenal Insufficiency in Males with Adrenoleukodystrophy: Case Series and Literature Review.
    Eng L; Regelmann MO
    J Pediatr; 2019 Aug; 211():211-214. PubMed ID: 31101408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy.
    de Beer M; Engelen M; van Geel BM
    Neurology; 2014 Dec; 83(24):2227-31. PubMed ID: 25378668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.
    Kemp S; Berger J; Aubourg P
    Biochim Biophys Acta; 2012 Sep; 1822(9):1465-74. PubMed ID: 22483867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects.
    Berger J; Gärtner J
    Biochim Biophys Acta; 2006 Dec; 1763(12):1721-32. PubMed ID: 16949688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies.
    Turk BR; Theda C; Fatemi A; Moser AB
    Int J Dev Neurosci; 2020 Feb; 80(1):52-72. PubMed ID: 31909500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.
    Engelen M; Kemp S; de Visser M; van Geel BM; Wanders RJ; Aubourg P; Poll-The BT
    Orphanet J Rare Dis; 2012 Aug; 7():51. PubMed ID: 22889154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked adrenoleukodystrophy: pathogenesis and treatment.
    Engelen M; Kemp S; Poll-The BT
    Curr Neurol Neurosci Rep; 2014 Oct; 14(10):486. PubMed ID: 25115486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of X-linked adrenoleukodystrophy.
    Berger J; Forss-Petter S; Eichler FS
    Biochimie; 2014 Mar; 98(100):135-42. PubMed ID: 24316281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked adrenoleukodystrophy.
    Moser HW; Mahmood A; Raymond GV
    Nat Clin Pract Neurol; 2007 Mar; 3(3):140-51. PubMed ID: 17342190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history.
    Kemp S; Huffnagel IC; Linthorst GE; Wanders RJ; Engelen M
    Nat Rev Endocrinol; 2016 Oct; 12(10):606-15. PubMed ID: 27312864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Natural History of Adrenal Insufficiency in X-Linked Adrenoleukodystrophy: An International Collaboration.
    Huffnagel IC; Laheji FK; Aziz-Bose R; Tritos NA; Marino R; Linthorst GE; Kemp S; Engelen M; Eichler F
    J Clin Endocrinol Metab; 2019 Jan; 104(1):118-126. PubMed ID: 30252065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel
    Cho YK; Lee SY; Kim SW
    Endocrinol Metab (Seoul); 2020 Mar; 35(1):188-191. PubMed ID: 32207279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.
    Eichler F; Duncan C; Musolino PL; Orchard PJ; De Oliveira S; Thrasher AJ; Armant M; Dansereau C; Lund TC; Miller WP; Raymond GV; Sankar R; Shah AJ; Sevin C; Gaspar HB; Gissen P; Amartino H; Bratkovic D; Smith NJC; Paker AM; Shamir E; O'Meara T; Davidson D; Aubourg P; Williams DA
    N Engl J Med; 2017 Oct; 377(17):1630-1638. PubMed ID: 28976817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.